Aspiriant LLC’s iShares Core 60/40 Balanced Allocation ETF AOR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$32.8M	Buy	509,424 +28,095	+6%	+$1.85M	0.93%	18
2025 Q4	$31.3M	Buy	481,329 +15,686	+3%	+$1.02M	0.9%	20
2025 Q3	$30M	Buy	465,643 +13,448	+3%	+$841K	0.92%	20
2025 Q2	$27.8M	Sell	452,195 -11,733	-3%	-$685K	0.89%	21
2025 Q1	$26.7M	Buy	463,928 +37,047	+9%	+$2.16M	0.93%	16
2024 Q4	$24.5M	Sell	426,881 -17,564	-4%	-$1.03M	0.88%	17
2024 Q3	$26.3M	Sell	444,445 -3,309	-0.7%	-$190K	1%	16
2024 Q2	$25.2M	Buy	447,754 +32,854	+8%	+$1.82M	1.03%	16
2024 Q1	$23.1M	Sell	414,900 -49,052	-11%	-$2.65M	0.96%	17
2023 Q4	$24.7M	Sell	463,952 -56,750	-11%	-$2.86M	1.11%	17
2023 Q3	$25.7M	Buy	520,702 +34,717	+7%	+$1.77M	1.32%	15
2023 Q2	$25M	Buy	485,985 +14,519	+3%	+$731K	1.26%	15
2023 Q1	$23.6M	Sell	471,466 -167,003	-26%	-$8.22M	1.23%	15
2022 Q4	$30.1M	Sell	638,469 -1,104,893	-63%	-$52M	1.53%	11
2022 Q3	$78.1M	Buy	1,743,362 +394,690	+29%	+$19.1M	3.82%	6
2022 Q2	$64.7M	Buy	1,348,672 +1,175,314	+678%	+$59.2M	3.12%	6
2022 Q1	$9.35M	Buy	173,358 +32,108	+23%	+$1.75M	0.51%	26
2021 Q4	$8.06M	Buy	141,250 +47,949	+51%	+$2.72M	0.43%	31
2021 Q3	$5.17M	Buy	93,301 +11,260	+14%	+$635K	0.3%	42
2021 Q2	$4.59M	Buy	82,041 +28,166	+52%	+$1.56M	0.26%	42
2021 Q1	$2.89M	Buy	53,875 +16,076	+43%	+$855K	0.18%	53
2020 Q4	$1.97M	Buy	37,799 +12,593	+50%	+$634K	0.13%	66
2020 Q3	$1.22M	Buy	+25,206	New	+$1.22M	0.1%	87